SuperPath approach is a recommendable option in frail patients with femoral neck fractures: a case-control study
| Autor: | Annalisa De Cicco, Alfredo Schiavone Panni, Adriano Braile, G. Bruno, Giuseppe Toro, Giacomo Errico, Antonio Benedetto Cecere |
|---|---|
| Přispěvatelé: | Cecere, Antonio Benedetto, De Cicco, Annalisa, Bruno, Gaetano, Toro, Giuseppe, Errico, Giacomo, Braile, Adriano, Schiavone Panni, Alfredo |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Blood transfusion medicine.medical_treatment Arthroplasty Replacement Hip Frail Elderly Femoral Neck Fractures Fibrinolytic Agents Hip replacement Antithrombotic Medicine Humans Orthopedics and Sports Medicine Aged Retrospective Studies Hip fracture business.industry General Medicine medicine.disease Polytrauma Surgery Treatment Outcome Case-Control Studies Orthopedic surgery Hemiarthroplasty business Complication |
| Zdroj: | Archives of orthopaedic and trauma surgery. 142(11) |
| ISSN: | 1434-3916 |
| Popis: | Introduction The treatment of intracapsular femoral neck fractures (FNFs) in the elderly is usually based on hip replacement, both total hip arthroplasty (THA) and hemiarthroplasty (HA). Recently, several tissue-sparing approaches for hip arthroplasty had been described with promising results in terms of hospitalization length, blood loss and dislocation rate. The aim of the present study was to compare the blood loss and the transfusion rate in a cohort of patients with FNF treated using an HA through both the SuperPath (SP) and the traditional posterolateral (PL) approaches. Materials and methods We retrospectively collected data from patients affected by FNFs between January 2018 and February 2020. All patients with intracapsular FNF treated with a single HA implant (Profemur L, MicroPort Orthopedics Inc., USA) via PL or SP approaches were included. Exclusion criteria were pathological fractures, polytrauma and preoperatively transfused patients. Results Thirty-five patients were included and analysed in the present study. 17 patients were classified in the SP group, and 18 in the PL one. The rate of antithrombotic therapy was higher in the SP group compared with the PL group [10 (58, 82%) vs 4 (22, 2%)]. While the two groups did not differ in terms of preoperative haemoglobin (Hb), 48 h postoperative Hb and Hb reduction, a significative difference was observed in terms of blood transfusion rate (1 SP vs 9 PL, p = 0.0072). Conclusions The SuperPath approach in patients with FNF under antithrombotic therapy assures lower transfusion rate, potentially reducing complication rates and improving patients' outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink